Covid-19 in kidney transplant recipients with immunosuppressive therapy: a case report and review article

Background: Since the outbreak of COVID-19, various treatments have been frequently reported for patients infected with this virus, especially in transplant patient recipients. Investigating o the literature and organ transplant patients with COVID-19, it could pave the way to understanding, handlin...

Full description

Bibliographic Details
Main Authors: Zahra Sheikhalipour, Masood Faghihdinevari, Hanieh Salehi-Pourmehr, Maryam Khameneh, Leila Vahedi
Format: Article
Language:English
Published: Babol University of Medical Sciences 2022-01-01
Series:Caspian Journal of Internal Medicine
Subjects:
Online Access:http://caspjim.com/article-1-2573-en.html
_version_ 1811272489934782464
author Zahra Sheikhalipour
Masood Faghihdinevari
Hanieh Salehi-Pourmehr
Maryam Khameneh
Leila Vahedi
author_facet Zahra Sheikhalipour
Masood Faghihdinevari
Hanieh Salehi-Pourmehr
Maryam Khameneh
Leila Vahedi
author_sort Zahra Sheikhalipour
collection DOAJ
description Background: Since the outbreak of COVID-19, various treatments have been frequently reported for patients infected with this virus, especially in transplant patient recipients. Investigating o the literature and organ transplant patients with COVID-19, it could pave the way to understanding, handling, and treatment of COVID-19. Methods: We had a brief review of the literature on immunosuppressive therapy in kidney transplants infected with COVID-19 based on the PubMed Database by keywords “kidney, transplant, COVID-19, and immunosuppress” after hospitalization of a kidney transplant reception infected with COVID-19. He had already been recorded in the Organ Transplant Registry (ID≠ 64510) of Tabriz University of Medical Sciences /Iran. Results: We reported the clinical course of a 45-year-old man with a history of kidney transplant and immunotherapy who was infected with COVID-19 with respiratory infections and positive RT-PCR (Real-time polymerase chain reaction). He was treated with hydroxychloroquine, Kaletra, Cellcept, and Prednisolone for 5 days, and finally discharged from the hospital. In addition, the reviewing of 48 papers with 745 samples showed that immunosuppressant medications alone could be a therapeutic choice in kidney transplants infected with COVID-19 with careful management. Conclusion: The patients with organ transplantation infected with COVID-19 may show different clinical signs, clinical course, and prognosis due to underlying diseases and the use of immunosuppressant medications. It might be best to continue taking the immunosuppressant medications but to modify them based on patients conditions such as clinical symptoms, laboratory results, paraclinical examinations.
first_indexed 2024-04-12T22:41:14Z
format Article
id doaj.art-29d544d09c2e4d8b89c1e9acc2422668
institution Directory Open Access Journal
issn 2008-6164
2008-6172
language English
last_indexed 2024-04-12T22:41:14Z
publishDate 2022-01-01
publisher Babol University of Medical Sciences
record_format Article
series Caspian Journal of Internal Medicine
spelling doaj.art-29d544d09c2e4d8b89c1e9acc24226682022-12-22T03:13:42ZengBabol University of Medical SciencesCaspian Journal of Internal Medicine2008-61642008-61722022-01-0113Covid 19 Supplement 2161172Covid-19 in kidney transplant recipients with immunosuppressive therapy: a case report and review articleZahra Sheikhalipour0Masood Faghihdinevari1Hanieh Salehi-Pourmehr2Maryam Khameneh3Leila Vahedi4 1. Medical and Surgical Department, Nursing and Midwifery School, Organ Transplant Registry, Tabriz University of Medical Sciences, Iran Liver and Gastrointestinal Diseases Research Center, Organ Transplant Registry, Tabriz University of Medical Sciences, Tabriz, Iran Research Center for Evidence-Based Medicine, Iranian EBM Centre: A Joanna Briggs Institute (JBI) Center of Excellence, Tabriz University of Medical Sciences, Tabriz, Iran Student Research Committee, Islamic Azad University of Tabriz, Tabriz, Iran Liver and Gastrointestinal Diseases Research Center, Organ Transplant Registry, Tabriz University of Medical Sciences, Tabriz, Iran Background: Since the outbreak of COVID-19, various treatments have been frequently reported for patients infected with this virus, especially in transplant patient recipients. Investigating o the literature and organ transplant patients with COVID-19, it could pave the way to understanding, handling, and treatment of COVID-19. Methods: We had a brief review of the literature on immunosuppressive therapy in kidney transplants infected with COVID-19 based on the PubMed Database by keywords “kidney, transplant, COVID-19, and immunosuppress” after hospitalization of a kidney transplant reception infected with COVID-19. He had already been recorded in the Organ Transplant Registry (ID≠ 64510) of Tabriz University of Medical Sciences /Iran. Results: We reported the clinical course of a 45-year-old man with a history of kidney transplant and immunotherapy who was infected with COVID-19 with respiratory infections and positive RT-PCR (Real-time polymerase chain reaction). He was treated with hydroxychloroquine, Kaletra, Cellcept, and Prednisolone for 5 days, and finally discharged from the hospital. In addition, the reviewing of 48 papers with 745 samples showed that immunosuppressant medications alone could be a therapeutic choice in kidney transplants infected with COVID-19 with careful management. Conclusion: The patients with organ transplantation infected with COVID-19 may show different clinical signs, clinical course, and prognosis due to underlying diseases and the use of immunosuppressant medications. It might be best to continue taking the immunosuppressant medications but to modify them based on patients conditions such as clinical symptoms, laboratory results, paraclinical examinations.http://caspjim.com/article-1-2573-en.htmlcovid- 19kidney transplantimmunosuppressantreview
spellingShingle Zahra Sheikhalipour
Masood Faghihdinevari
Hanieh Salehi-Pourmehr
Maryam Khameneh
Leila Vahedi
Covid-19 in kidney transplant recipients with immunosuppressive therapy: a case report and review article
Caspian Journal of Internal Medicine
covid- 19
kidney transplant
immunosuppressant
review
title Covid-19 in kidney transplant recipients with immunosuppressive therapy: a case report and review article
title_full Covid-19 in kidney transplant recipients with immunosuppressive therapy: a case report and review article
title_fullStr Covid-19 in kidney transplant recipients with immunosuppressive therapy: a case report and review article
title_full_unstemmed Covid-19 in kidney transplant recipients with immunosuppressive therapy: a case report and review article
title_short Covid-19 in kidney transplant recipients with immunosuppressive therapy: a case report and review article
title_sort covid 19 in kidney transplant recipients with immunosuppressive therapy a case report and review article
topic covid- 19
kidney transplant
immunosuppressant
review
url http://caspjim.com/article-1-2573-en.html
work_keys_str_mv AT zahrasheikhalipour covid19inkidneytransplantrecipientswithimmunosuppressivetherapyacasereportandreviewarticle
AT masoodfaghihdinevari covid19inkidneytransplantrecipientswithimmunosuppressivetherapyacasereportandreviewarticle
AT haniehsalehipourmehr covid19inkidneytransplantrecipientswithimmunosuppressivetherapyacasereportandreviewarticle
AT maryamkhameneh covid19inkidneytransplantrecipientswithimmunosuppressivetherapyacasereportandreviewarticle
AT leilavahedi covid19inkidneytransplantrecipientswithimmunosuppressivetherapyacasereportandreviewarticle